ALPHAHELIX MOL.DIAGN. SK1 (4MB) — Capital Reinvestment Ratio
Latest as of December 2022:
0.10x
ALPHAHELIX MOL.DIAGN. SK1 (4MB) has a Capital Reinvestment Ratio of 0.10x as of December 2022, meaning it reinvests 0% of its operating cash flow (€2.87 Million) in capital expenditures (€288.09K). See ALPHAHELIX MOL.DIAGN. SK1 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.10x
Capex / Operating Cash Flow
Operating Cash Flow
€2.87 Million
EUR
Capital Expenditures
€288.09K
EUR
Data as of
Dec 2022
Most recent filing
ALPHAHELIX MOL.DIAGN. SK1 Capital Reinvestment Ratio (2022–2022)
This chart tracks ALPHAHELIX MOL.DIAGN. SK1's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for ALPHAHELIX MOL.DIAGN. SK1 (2022–2022)
Year-by-year Capital Reinvestment Ratio for ALPHAHELIX MOL.DIAGN. SK1 from 2022 to 2022. For live market cap and broader valuation context, see ALPHAHELIX MOL.DIAGN. SK1 market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.10x | €2.87 Million | €288.09K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow